Type 5 phosphodiesterase regulates glioblastoma multiforme aggressiveness and clinical outcome

Expression of type 5 phosphodiesterase (PDE5), a cGMP-specific hydrolytic enzyme, is frequently altered in human cancer, but its specific role in tumorigenesis remains controversial. Herein, by analyzing a cohort of 69 patients affected by glioblastoma multiforme (GBM) who underwent chemo- and radio...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Cesarini, Valeriana, Martini, Maurizio, Vitiani, Lucia Ricci, Gravina, Giovanni Luca, Agostino, Silvia Di, Graziani, Grazia, D'Alessandris, Quintino Giorgio, Pallini, Roberto, Larocca, Luigi M, Rossi, Pellegrino, Jannini, Emmanuele A, Dolci, Susanna
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2017
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5355091/
https://ncbi.nlm.nih.gov/pubmed/28099939
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.14656
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars